Antisense oligonucleotides (ASOs) can bind to complementary sequences in mRNA to reduce the expression of specific proteins. Which oligonucleotide could be used as an ASO to treat a form of Creutzfeld-Jakob disease (CJD) caused by a specific mutation in the PrP prion protein?
a. 5'UUCACCAAG3'
b. 5'AAGUGGUUC3'
c. 5'GAACCACUU3'
d. 5'CUUGGUGAA3'
e. 5'GAAGGUCUU3'